Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific antigen membrane therapy
Jaxon Quillen, Daniel S. Childs, Yael N. Kusne, Mrinal M. Patnaik et al.
Citations
1 citations
Journal
Haematologica
Topics
Radiopharmaceutical Chemistry and Applications
Field-Weighted Citation Impact (FWCI)
1.36
article
Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific antigen membrane therapy
Jaxon Quillen, Daniel S. Childs, Yael N. Kusne, Mrinal M. Patnaik, Oliver A. Sartor, Osama Mosalem, Geoffrey B. Johnson, Skye Buckner‐Petty, Miguel Muniz
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
HaematologicaVol. 110(9)
Institutions
Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US)